PTGX Market Cap & Key Metrics
Protagonist Therapeutics, Inc.
$132.04
-$3.22(-2.38%)
50
Overall
40
Value
50
Tech
60
Quality
Market Cap
$8.62B
Volume
972.95K
52W Range
$77.00 - $160.81
Target Price
$176.88
PTGX market cap is $8.62B. This page lists Protagonist Therapeutics, Inc.'s P/E ratio, EPS estimates, dividend yield, payout ratio and MarketXLS scores.
PTGX Key Metrics
- Market cap
- $8.62B
- P/E ratio (current-year EPS estimate)
- 28.77
- EPS estimate, current year
- $4.59
- EPS growth, 3-year
- +0.00%
- Value score
- 40
- Quality score
- 60
- Technical score
- 50
| Fiscal year | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|
| Revenue | $28.63M | $64.0K | $30.93M | $20.06M | - |
| EBITDA | -$61.52M | -$75.81M | -$38.99M | -$35.86M | -$36.74M |
| EPS | $-1.92 | $-2.98 | - | - | - |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | PTGX | $132.04 | -2.4% | 972.95K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Protagonist Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW